Memory impairment in patients with late-onset major depression: the effect of antidepressant therapy

Roberto Gallassi1, Rita Di Sarro, Angela Morreale

  • 1Centre for the Neurological Study of Cerebral Aging, Department of Neurological Sciences, University of Bologna, Italy. roberto.gallassi@unibo.it

Abstract

Insights

Major depression (MD) negatively impacts cognitive functions, particularly memory. While antidepressant therapy improves cognition, deficits may persist even after remission, suggesting both temporary and long-term depressive effects.

Area of Science:

  • Neuroscience
  • Psychiatry
  • Gerontology

Background:

  • Cognitive deficits are noted in major depression (MD), but remain incompletely understood.
  • Older adults with MD may experience specific cognitive impairments.

Purpose of the Study:

  • To investigate cognitive functions in older adults with MD during an episode and after remission.
  • To evaluate the impact of antidepressant therapy (ADT) on cognitive performance.

Main Methods:

  • 48 drug-free patients over 50 with MD and 15 controls underwent cognitive testing (attention, memory).
  • Patients were assessed at baseline and 6 months after ADT (fluoxetine or reboxetine).
  • Cognitive assessments included Mini Mental Status Examination (MMSE) and Wechsler Memory Scale (WMS).

Main Results:

  • MD patients performed worse than controls on MMSE, WMS, and autobiographical memory at baseline.
  • After remission, patients showed significant cognitive improvement but still differed from controls in complex tasks.
  • No significant differences in cognitive improvement were observed between fluoxetine and reboxetine groups.

Conclusions:

  • Depression significantly impairs memory, with incomplete recovery post-remission.
  • Both state-dependent and trait-dependent factors likely contribute to persistent memory deficits in MD.
  • Findings suggest ADT benefits cognition, but residual deficits may remain in older adults with MD.

Related Concept Videos

Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
Long-term Depression01:03

Long-term Depression

Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over time, all...
Long-term Depression01:05

Long-term Depression

Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Antidepressant Drugs: Overview01:25

Antidepressant Drugs: Overview

Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...